Those of Us Who Love Working In Pharma Have a Responsibility To Patients
I think something is brewing in the pharma industry that isn’t getting the attention it deserves. Experience is leaving. Whether through retirement, multiple cycles of reorganizations and layoffs, or simply …
Pharma Is Losing Experience. We Should Be Worried. Read More
Pharma spends billions each year on DTC advertising to consumers, but too often assesses the performance of the DTC Managers responsible for that investment using metrics that tell you very …
Are Pharma Companies Measuring Their DTC Managers Wrong? Read More
Pharma’s DTC channel of choice is (and likely will remain for some time) TV. IQVIA estimates pharma spent over $6 billion on DTC TV advertising campaigns for 75 brands spending …
Prescription Drug Marketing Is Changing. The Bigger Question Is Whether Pharma Marketers Are Changing With It Read More
The report’s central message is that healthcare professionals still have substantial influence, but they no longer have a monopoly on health authority. Patients operate in an information environment filled with family, …
Key points from the 2026 Edelman/Yale health trust analysis Read More
Drug makers are scrambling to produce the next wave of obesity drugs. Just one problem. The payers expected to pay are pushing back. For years, the obesity drug conversation has …
The Weight-Loss Drug Pipeline Has a Problem: Who Will Pay? Read More
The FTC found that the six largest PBMs manage more than 90% of U.S. prescriptions, while the three largest processed nearly 80% of roughly 6.6 billion prescriptions in 2023. It …
Replacing PBMs With a Better Pricing Model Read More
Pfizer currently has one of the weakest signals in oncology physician engagement. Pfizer spent $43 billion to acquire Seagen and transform itself into an oncology powerhouse—yet its oncology MSL organization …
Pfizer Spent $43 Billion to Become an Oncology Leader. So Why Do Its MSLs Rank Last With Oncologists? Read More
Few sentences can destroy billions of dollars of market value faster than this one: “The study did not meet its primary endpoint.” Stocks plummet. Headlines pronounce the trial a failure. …
The Drug Missed Its Endpoint. What Does That Actually Mean? Read More